期刊文献+

肝动脉化疗栓塞联合CT引导射频消融序贯治疗中小肝癌的临床应用 被引量:33

Sequential treatment with TACE and CT-guided RFA for small and moderate sized HCC
暂未订购
导出
摘要 目的探讨肝动脉化疗栓塞(TACE)联合CT引导射频消融(RFA)序贯治疗原发性中小肝癌的临床应用。方法对59例肝细胞性中小肝癌患者实施TACE联合CT引导RFA序贯治疗。结果 59例患者初次治疗,共80枚病灶,行TACE和RFA序贯治疗技术成功率100%。术后随访6~24个月,21例患者有病灶残余,再次行RFA或序贯治疗,3例再次联合放射性125I粒子植入治疗后,病灶控制良好。并发症有胆汁瘤合并胆道感染1例、门静脉分支血栓1例。结论 TACE联合CT引导RFA序贯治疗中小肝癌是一种微创、有效的方法,同时注意手术操作细节,对提高手术成功率,降低手术并发症有重要意义。 Objective To investigate the clinical application of sequential therapy with transarterial chemoembolization (TACE) and CT-guided radiofrequency ablation (RFA) in treating small or moderate sized hepatocellular carcinoma (HCC). Methods A total of 59 patients with small or moderate sized HCC received sequential TACE and CT-guided RFA. The technical and clinical results were analyzed. Results A total of 80 hepatic lesions were detected in 59 patients. The technical success rate of sequential treatment with TACE and CT-guided RFA was 100%. Patients were followed up for 6 - 24 months. CT-guided RFA or sequential treatment was repeated in 21 patients because of residual lesions. Additional ^125I seed implantation was carried out in three patients, and the lesions were well controlled. Complications included biloma complicated by bile duct infection (n = 1) and portal vein branch thrombosis (n = 1). Conclusion The sequential treatment with TACE and CT-guided RFA is an effective and mini-invasive therapeutic option for small or moderate sized HCC.(J Intervent Radiol, 2012, 21: 301-304)
出处 《介入放射学杂志》 CSCD 北大核心 2012年第4期301-304,共4页 Journal of Interventional Radiology
关键词 原发性肝癌 肝动脉化疗栓塞 射频消融 序贯治疗 primary hepatocellular carcinoma transarterial chemoembolization radiofrequency ablation sequential treatment
  • 相关文献

参考文献9

  • 1Lam VW, Ng KK, Chok KS, et al. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma : analysis of risk factors and prognostic factors [J]. Ann Surg Oncol, 2008, 15 : 782 - 790.
  • 2Matsui O, Kadoya M, Yoshikawa J, et al. Subsegmental transcatheter arterial embolization for stoat1 hepatocellular carcinomas: local therapeutic effect and 5-year survival rate [J]. Cancer Chemother Pharmacol, 1994, 33(Suppl) : $84- $88.
  • 3Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J]. Ann Surg, 2006, 243:321 -328.
  • 4Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin [J]. AJR, 2007, 188:480 - 488.
  • 5Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)[J]. Eur Radiol, 2006, 16:661 - 669.
  • 6张家文,刘斌.CT引导下介入治疗肝癌[J].介入放射学杂志,2004,13(1):86-89. 被引量:3
  • 7Dodd GD 3rd, Soulen MC, Kane RA, et al. Minimally invasive treat-ment of malignant hepatic tumors at the threshold of a major break through[J]. Raidiographics, 2000, 20:9 - 27.
  • 8陈敏华.射频消融治疗难治性肝脏肿瘤操作技巧[J].中国实用外科杂志,2008,28(8):665-668. 被引量:8
  • 9Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liv- er tumors with percutaneous radio-frequency ablation : complications encountered in a muhicenter study [J]. Radiology, 2003, 226: 441- 451.

二级参考文献15

  • 1霍苓,陈敏华,严昆,张晖,高文,杨薇,戴莹,黄信孚.胆囊旁肝肿瘤射频消融治疗附加方法及疗效[J].中华超声影像学杂志,2005,14(6):437-440. 被引量:12
  • 2陈敏华,严昆,戴莹,杨薇,高文,廖盛日,吴薇,张晓鹏,黄信孚.经皮射频治疗肝肿瘤中肠穿孔预防措施探讨[J].中国介入影像与治疗学,2005,2(4):256-260. 被引量:10
  • 3陈敏华,杨薇,严昆,高文,戴莹,王艳滨,霍苓,张晖,黄信孚.应用射频消融法对肝肿瘤患者进行规范化治疗[J].中华医学杂志,2005,85(25):1741-1746. 被引量:69
  • 4Gazelle GS,Goldberg SN ,Solbiati L,et al. Tumor ablation with radio-frequency energy[J]. Radiology,2000,217(3) :633 -646.
  • 5Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with pereutaneous radio-frequency ablation: complications encountered in a multiccntcr study [ J ]. Radiology, 2003,226 (2) :441 -451.
  • 6Chopra S, Dodd Ill GD, Chanin MP, et al. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety [ J ]. Am J Roentgenol,2003,180 ( 3 ) :697 - 701.
  • 7Choi D,Lim HK,Kim MJ,et al. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract [ J ]. Am J Roentgenol, 2004, 183(5 ) : 1417 - 1424.
  • 8Poon RT, Ng KK, Lam CM, et al. Radiofrequency ablation for subcapsular hepatocellular carcinoma [ J ]. Ann Surg Oncol, 2004,11 (3) :281 -289.
  • 9Kapoor BS, Hunter DW. Injection of subphrenic saline during radiofrequency ablation to minimize diaphragmatic injury[ J]. Cardiovasc Intervent Radiol,2003,26 (3) :302 - 304.
  • 10Shibata T, limuro Y, Ikai I, et al. Percutaneous radiofrequency ablation therapy after intrathoraeie saline solution infusion for liver tumor in the hepatic dome[J]. J Vase Interv Radiol,2002,13 (3) :313 -315.

共引文献9

同被引文献323

引证文献33

二级引证文献251

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部